share_log

We Think Zimmer Biomet Holdings' (NYSE:ZBH) Profit Is Only A Baseline For What They Can Achieve

Simply Wall St ·  Feb 15 06:25

Even though Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be missing some promising details.

earnings-and-revenue-history
NYSE:ZBH Earnings and Revenue History February 15th 2024

How Do Unusual Items Influence Profit?

Importantly, our data indicates that Zimmer Biomet Holdings' profit was reduced by US$200m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Zimmer Biomet Holdings to produce a higher profit next year, all else being equal.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Zimmer Biomet Holdings' Profit Performance

Unusual items (expenses) detracted from Zimmer Biomet Holdings' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Zimmer Biomet Holdings' statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. While conducting our analysis, we found that Zimmer Biomet Holdings has 1 warning sign and it would be unwise to ignore it.

Today we've zoomed in on a single data point to better understand the nature of Zimmer Biomet Holdings' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment